Opivibo, the first cancer immunotherapy drug in China, approved by the Chinese National Drug Administration and Supervision Agency for indications of treatment non-small cell lung cancer with history
Day: June 18, 2018
SIPRI: Nuclear weapons still being developed
“FREE POWER” sold by Cycle · Olympics is introduced on TV.
M 5.3 – 1km SSW of Takatsuki, Japan
TOYOTA GAZOO Racing Wins Le Mans